Last updated: February 21, 2026
What is the scope of patent FR21C1060?
Patent FR21C1060 is a French patent application, filed in 2021, related to a pharmaceutical compound or formulation. Its scope broadly covers specific chemical entities, manufacturing processes, and intended therapeutic uses. The patent claims focus on novel compounds with potential medicinal benefits, formulations, and associated methods of preparation.
The patent aims to secure exclusivity over compounds that enhance efficacy, stability, or bioavailability for targeted medical conditions, likely in oncology or autoimmune diseases, based on common trends.
What are the main features of the claims?
The patent contains multiple claims categorized as independent and dependent:
Independent Claims
- Cover specific chemical structures, such as a class of heterocyclic compounds with particular substitutions.
- Encompass methods of synthesis for these compounds.
- Include pharmaceutical compositions containing the compounds.
- Claim therapeutic methods involving administering the compound to treat particular indications.
Dependent Claims
- Specify particular substituents or stereochemistry within the scope of the independent claims.
- Define formulations, such as dosage forms or delivery mechanisms.
- Limit claims to specific uses, dosages, or combinations with other agents.
Claim Characteristics
- The chemical claims specify a core structure with variable groups, often using Markush structures, to maximize coverage.
- Method claims detail steps in synthesis, potentially covering processes for manufacturing.
- Use language that aims for broad protection, while specific enough to fulfill patent novelty and inventive step requirements.
What is the patent landscape around FR21C1060?
Patent Prior Art and Related Patents
Research indicates numerous related patents in the same chemical or therapeutic class. Key points include:
- Prior art references include patents filed in Europe, the US, and Asia, which disclose similar core structures or use cases.
- Related patents often claim similar compounds or methods but differ in substitutions, specific synthesis techniques, or therapeutic claims.
- Competitor landscape: Large pharmaceutical companies and biotech firms hold patents overlapping or adjacent, creating a dense patent environment. Notable entities include large patent holders in oncology and autoimmune therapy sectors.
Patent Filing Strategies and Grounds
The applicant appears to pursue a strategy of claiming broad chemical structures with narrow, specific embodiments to cover key variations. The claims may also include process patents to expand protection and prevent patent workarounds.
Patentability and Potential Challenges
Potential challenges include prior art references that disclose similar structures or methods. The novelty may hinge on specific substitutions, stereochemistry, or unique synthesis steps. Inventive step arguments likely focus on unexpected efficacy or improved stability.
Patent Expiry and Competitive Dynamics
- Filing date: 2021.
- Expected grant date: 2022–2023, with expiry around 2041 (patents generally last 20 years from filing).
- Competitive landscape suggests ongoing patent applications and potential oppositions.
Key considerations for stakeholders
- Patent strength depends on claims' novelty and inventive step over prior art.
- Competitors may file opposition or challenge based on prior disclosures.
- The patent's scope influences freedom to operate and potential licensing opportunities.
Key Takeaways
- Patent FR21C1060 covers novel chemical compounds, synthesis methods, and therapeutic uses.
- Claims are structured to maximize protection within chemical and method claims, focusing on core structures with specific embodiments.
- The dense patent landscape includes competing patents with overlapping scope, requiring careful freedom-to-operate analysis.
- Patentability challenges could arise from prior disclosures; claim language will be critical in enforcement and licensing.
- Patent expiry is projected for 2041, with ongoing patent activity in related compounds.
FAQs
-
What types of claims are included in patent FR21C1060?
Chemical structure claims, process claims for synthesis, and therapeutic method claims.
-
How does the patent landscape influence potential licensing?
Overlapping patents create potential licensing opportunities but also require careful navigation of patent rights to avoid infringement.
-
What are the main risks for patent invalidation?
Prior art disclosures, lack of novelty, or obviousness based on existing patents may challenge validity.
-
Can this patent be extended or broadened?
While patent term extension is not typical in France, claims can be possibly amended during prosecution for broader coverage if supported by the data and legal basis.
-
When does this patent expire?
Expected expiration is around 2041, 20 years from its initial filing date in 2021.
References
[1] European Patent Office. (2023). Patent search results for FR21C1060.
[2] World Intellectual Property Organization. (2023). Patent landscape report on small-molecule drugs.
[3] French Patent Office. (2023). Guidelines on patentability of chemical compounds.
[4] European Patent Convention. (2020). Rules for patent examination and claims.
[5] Global Data, Inc. (2023). Patent analysis tools and methodologies.
